Human immunodeficiency virus (HIV) infections cause severe CD4+ T cell depletion leading to chronic inflammation and immune activation, impaired barrier function, and microbial translocation. Even under effective antiretroviral therapy, these processes persist, leading to gut microbiome dysbiosis and disturbance of microbiome–host homeostasis. This systematic review aims at analyzing how gut microbiome and host immune system influence each other during HIV pathogenesis. An online search applying the PubMed database was conducted. The number of total results (n = 35) was narrowed down to 5 relevant studies focusing on the interaction between the host and gut microbiome, whereas strict exclusion criteria were applied, thereby assuring that no other comorbidities impacted study results. Our analyses revealed that gut microbiome diversity correlated positively with CD4+ T cell counts and negatively with microbial translocation markers. However, quantitative changes in bacterial richness did not consistently correlate with the numbers of metabolically active bacterial populations. Despite the reported increase in potentially pathogenic bacteria and, conversely, decrease in protective populations, the gut microbiota exhibited immune-modulating qualities given that mucosal inflammatory sequelae were dampened by decreasing pro-inflammatory and accelerating anti-inflammatory cytokine responses. Future research is needed to further elucidate these findings, to gain a deeper insight into host–microbiota interactions and to develop novel therapeutic strategies.
Kotler DP , Giang TT, Thiim M, Nataro JP, Sordillo EM, Orenstein JM: Chronic bacterial enteropathy in patients with AIDS. J Infect Dis 171, 552–558 (1995)
Bhaijee F , Subramony C, Tang SJ, Pepper DJ: Human immunodeficiency virus-associated gastrointestinal disease: common endoscopic biopsy diagnoses. Patholog Res Int 2011, 247923 (2011)
Cabada MM , White AC, Jr: Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis 23, 494–499 (2010)
Sun HY , Chen MY, Wu MS, Hsieh SM, Fang CT, Hung CC, Chang SC: Endoscopic appearance of GI mycobacteriosis caused by the Mycobacterium avium complex in a patient with AIDS: case report and review. Gastrointest Endosc 61, 775–779 (2005)
Dinh DM , Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, Wanke CA, Ward HD: Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis 211, 19–27 (2015)
Ellis CL , Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM: Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 57, 363–370 (2011)
Mutlu EA , Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C, French A, Demarais P, Sun Y, Koenig L, Cox S, Engen P, Chakradeo P, Abbasi R, Gorenz A, Burns C, Landay A: A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 10, e1003829 (2014)
Vujkovic-Cvijin I , Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM, Huang Y, Somsouk M, Deeks SG, Hunt PW, Lynch SV, McCune JM: Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 5, 193ra91 (2013)
Lozupone CA , Rhodes ME, Neff CP, Fontenot AP, Campbell TB, Palmer BE: HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes 5, 562–570 (2014)
Zilberman-Schapira G , Zmora N, Itav S, Bashiardes S, Elinav H, Elinav E: The gut microbiome in human immunodeficiency virus infection. BMC Medicine 14, 83 (2016)
Parmentier M : CCR5 and HIV infection, a view from Brussels. Front Immunol 6, 295 (2015)
Guadalupe M , Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77, 11708–11717 (2003)
Brenchley JM , Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200, 749–759 (2004)
Marchetti G , Tincati C, Silvestri G: Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 26, 2–18 (2013)
Liu J , Williams B, Frank D, Dillon SM, Wilson CC, Landay AL: Inside out: HIV, the gut microbiome, and the mucosal immune system. J Immunol 198, 605–614 (2017)
Klatt NR , Funderburg NT, Brenchley JM: Microbial translocation, immune activation, and HIV disease. Trends Microbiol 21, 6–13 (2013)
Epple HJ , Allers K, Troger H, Kuhl A, Erben U, Fromm M, Zeitz M, Loddenkemper C, Schulzke JD, Schneider T: Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterol 139, 1289–1300 (2010)
Nazli A , Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C: Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 6, e1000852 (2010)
McHardy IH , Li X, Tong M, Ruegger P, Jacobs J, Borneman J, Anton P, Braun J: HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1, 26 (2013)
Dillon SM , Lee EJ, Kotter CV, Austin GL, Dong Z, Hecht DK, Gianella S, Siewe B, Smith DM, Landay AL, Robertson CE, Frank DN, Wilson CC: An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 7, 983–994 (2014)
Sharpstone D , Gazzard B: Gastrointestinal manifestations of HIV infection. Lancet 348, 379–383 (1996)
Ley RE , Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI: Evolution of mammals and their gut microbes. Science 320, 1647–1651 (2008)
De Filippo C , Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691–14696 (2010)
Yatsunenko T , Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczyns ki J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI: Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012)
Clarke SF , Murphy EF, O’Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O’Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O’Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD: Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63, 1913–1920 (2014)
Nowak P , Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, Hov JR, Noyan K, Vesterbacka J, Svärd J, Rudi K, Sönnerborg A: Gut microbiota diversity predicts immune status in HIV-1 infection. Aids 29, 2409–2418 (2015)
Vazquez-Castellanos JF , Serrano-Villar S, Latorre A, Artacho A, Ferrus ML, Madrid N, Vallejo A, Sainz T, Martínez-Botas J, Ferrando-Martínez S, Vera M, Dronda F, Leal M, Del Romero J, Moreno S, Estrada V, Gosalbes MJ, Moya A: Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol 8, 760–772 (2015)
Noguera-Julian M , Rocafort M, Guillen Y, Rivera J, Casadella M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, Rodríguez C, Carrillo J, Mothe B, Coll J, Bravo I, Estany C, Herrero C, Saz J, Sirera G, Torrela A, Navarro J, Crespo M, Brander C, Neg redo E, Blanco J, Guarner F, Calle ML, Bork P, Sönnerborg A, Clotet B, Paredes R: Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 5, 135–146 (2016)
Serrano-Villar S , Rojo D, Martinez-Martinez M, Deusch S, Vazquez-Castellanos JF, Bargiela R, Sainz T, Vera M, Moreno S, Estrada V, Gosalbes MJ, Latorre A, Seifert J, Barbas C, Moya A, Ferrer M: Gut bacteria metabolism impacts immune recovery in HIV-infected Individuals. EBioMedicine 8, 203–216 (2016)
Villar-Garcia J , Guerri-Fernandez R, Moya A, Gonzalez A, Hernandez JJ, Lerma E, Guelar A, Sorli L, Horcajada JP, Artacho A, D Auria G, Knobel H: Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: a double-blind, randomised, placebo-controlled trial. PLoS One 12, e0173802 (2017)
Sokol H , Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn’s disease patients. Proc Natl Acad Sci U S A 105, 16731–16736 (2008)
Carvalho BM , Saad MJ: Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm 2013, 986734 (2013)
Li RW , Wu S, Li W, Navarro K, Couch RD, Hill D, Urban JF Jr: Alterations in the porcine colon microbiota induced by the gastrointestinal nematode Trichuris suis. Infect Immun 80, 2150–2157 (2012)
Girardi E , Sabin CA, Monforte AD: Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 46 Suppl 1, S3–8 (2007)
Bertin J , Barat C, Belanger D, Tremblay MJ: Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells. J Neuroinflammation 9, 55 (2012)
Carroll KK , Guthrie N, Ravi K: Dolichol — function, metabolism, and accumulation in human tissues. Biochem Cell Biol 70, 382–384 (1992)
McPhee F , Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS: Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J 320, 681–686 (1996)
Wegiel B , Otterbein LE: Go green: the anti-inflammatory effects of biliverdin reductase. Front Pharmacol 3, 47 (2012)
Fowler CJ . Oleamide: a member of the endocannabinoid family? Br J Pharmacol 141, 195–196 (2004)
Wanyiri JW , Kanyi H, Maina S, Wang DE, Ngugi P, O’Connor R, Kamau T, Waithera T, Kimani G, Wamae CN, Mwamburi M, Ward HD: Infectious diarrhoea in antiretroviral therapy-naive HIV/AIDS patients in Kenya. Trans R Soc Trop Med Hyg 107, 631–638 (2013)
Rabe SM : Treatment of recurrent Clostridium difficile infection with fecal transplantation. Gastroenterol Nurs 37, 156–163 (2014)
Newman KM , Rank KM, Vaughn BP, Khoruts A: Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Gut Microbes 8, 303–309 (2017)